Kenji Sakamoto Selected Research

Ganglion Cysts (Ganglion)

1/2022	Pharmacological inhibition of Na+/K+-ATPase induces neurovascular degeneration and glial cell alteration in the rat retina.
4/2021	Metformin Protects against NMDA-Induced Retinal Injury through the MEK/ERK Signaling Pathway in Rats.
4/2019	Role of Neuron⁻Glia Signaling in Regulation of Retinal Vascular Tone in Rats.
1/2018	Iron-chelating agents attenuate NMDA-Induced neuronal injury via reduction of oxidative stress in the rat retina.
1/2018	Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity.
1/2018	Role of Glial Cells in μ-Opioid Receptor-Mediated Vasodilation in the Rat Retina.
10/2017	Opioid receptor activation is involved in neuroprotection induced by TRPV1 channel activation against excitotoxicity in the rat retina.
9/2017	Activation inhibitors of nuclear factor kappa B protect neurons against the NMDA-induced damage in the rat retina.
12/2016	Protective effects of PF-4708671 against N-methyl-d-aspartic acid-induced retinal damage in rats.
11/2016	Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenji Sakamoto Research Topics

Disease

26	Ganglion Cysts (Ganglion) 01/2022 - 08/2009
17	Ischemia 02/2022 - 01/2002
14	Coronary Artery Disease (Coronary Atherosclerosis) 08/2017 - 07/2006
13	Myocardial Infarction 02/2022 - 11/2014
12	Retinal Diseases 01/2018 - 05/2009
11	Heart Failure 01/2021 - 04/2010
11	Glaucoma 01/2020 - 05/2009
10	Acute Coronary Syndrome 02/2021 - 01/2013
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 04/2003
8	Diabetes Mellitus 03/2021 - 08/2008
8	Inflammation (Inflammations) 03/2020 - 08/2009
8	Neoplasms (Cancer) 01/2020 - 11/2006
8	Cataract (Cataracts) 01/2019 - 01/2008
8	Spasm (Spasms) 10/2016 - 01/2013
7	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2021 - 08/2009
7	Thrombosis (Thrombus) 01/2021 - 01/2016
6	Death (Near-Death Experience) 06/2022 - 01/2016
6	Atherosclerotic Plaque (Atheroma) 02/2021 - 08/2015
6	Atrial Fibrillation 01/2021 - 06/2014
6	Hypoxia (Hypoxemia) 01/2020 - 01/2011
6	Retinal Degeneration 01/2019 - 11/2010
5	Reperfusion Injury 02/2022 - 05/2009
4	Stroke (Strokes) 06/2022 - 06/2007
4	Retinopathy of Prematurity (Retrolental Fibroplasia) 08/2021 - 02/2016
4	Hyperemia 01/2021 - 01/2016
4	Hemorrhage 03/2020 - 03/2015
4	Unstable Angina 01/2020 - 01/2016
4	Pathologic Constriction (Stenosis) 01/2019 - 09/2015
4	Chronic Renal Insufficiency 10/2018 - 06/2015
4	Hypertension (High Blood Pressure) 01/2016 - 06/2007
3	ST Elevation Myocardial Infarction 02/2022 - 11/2014
3	Idiopathic Pulmonary Fibrosis 01/2022 - 01/2016
3	Pathologic Neovascularization 01/2020 - 01/2014
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2019 - 01/2013
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019 - 12/2015
3	Hyperglycemia 01/2019 - 01/2010
3	Atherosclerosis 10/2018 - 02/2011
3	Fetal Growth Retardation (Intrauterine Growth Retardation) 08/2014 - 08/2013
3	Hyperalgesia 01/2014 - 12/2012
2	Vascular Diseases (Vascular Disease) 08/2021 - 05/2015
2	Premature Birth (Birth, Premature) 08/2021 - 02/2013
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2016
2	Transthyretin-Related Hereditary Amyloidosis 11/2020 - 01/2019
2	MINOCA 05/2020 - 01/2020
2	Infections 04/2020 - 01/2016
2	Infarction (Infarctions) 03/2020 - 11/2014
2	Hypertrophy 03/2020 - 01/2019
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 12/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

34	Retinaldehyde (Retinal)IBA 08/2021 - 07/2004
27	N-Methylaspartate (NMDA)IBA 04/2021 - 05/2009
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 02/2013
10	Glutamic Acid (Glutamate)FDA Link 01/2018 - 08/2009
9	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2016 - 01/2010
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2021 - 11/2014
7	Atorvastatin (Lipitor)FDA Link 02/2021 - 08/2013
7	Streptozocin (Streptozotocin)FDA Link 01/2019 - 01/2008
6	Ezetimibe (Zetia)FDA Link 02/2021 - 08/2015
6	Oxygen (Dioxygen)IBA 01/2021 - 01/2014
6	Pharmaceutical PreparationsIBA 01/2019 - 04/2008
6	LipidsIBA 01/2019 - 07/2006
5	Vasodilator Agents (Vasodilators)IBA 08/2021 - 06/2007
5	oxidized low density lipoproteinIBA 12/2019 - 11/2014
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2018 - 08/2013
5	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017 - 05/2009
4	Rosuvastatin Calcium (Crestor)FDA Link 02/2022 - 11/2014
4	omega-Chloroacetophenone (Mace)IBA 01/2020 - 01/2016
4	LDL CholesterolIBA 12/2019 - 10/2015
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2008
4	Drinking WaterIBA 01/2019 - 01/2008
4	C-Reactive ProteinIBA 10/2018 - 01/2016
4	Lactic Acid (Lactate)FDA LinkGeneric 12/2016 - 12/2015
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2003
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 06/2015
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
3	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2020 - 01/2015
3	Troponin T (Troponin T1)IBA 11/2016 - 01/2013
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2016 - 03/2015
3	Everolimus FDA Link 01/2016 - 01/2014
3	N- (2- chloro- 4- ((6,7- dimethoxy- 4- quinazolinyl)oxy)phenyl)- N'- propylureaIBA 08/2014 - 02/2013
3	elcatoninIBA 01/2014 - 12/2012
3	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2014 - 12/2012
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2014 - 12/2012
3	AdiponectinIBA 08/2013 - 07/2006
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2011 - 02/2004
2	Indicators and Reagents (Reagents)IBA 06/2022 - 01/2015
2	Matrix Metalloproteinases (MMPs)IBA 02/2022 - 10/2018
2	AldehydesIBA 02/2022 - 05/2015
2	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2022 - 01/2016
2	ParvalbuminsIBA 04/2021 - 10/2013
2	RivaroxabanIBA 11/2020 - 03/2020
2	Interleukin-1 (Interleukin 1)IBA 04/2020 - 01/2016
2	Irbesartan FDA LinkGeneric 07/2019 - 10/2012

Therapy/Procedure

14	Percutaneous Coronary Intervention 02/2022 - 11/2014
13	Therapeutics 10/2020 - 01/2011
10	Intravitreal Injections 01/2022 - 01/2013
8	Stents 01/2021 - 03/2015
4	Catheter Ablation 01/2021 - 01/2015
3	Renal Dialysis (Hemodialysis) 12/2019 - 01/2015
2	Hemoperfusion 01/2022 - 01/2016